Recherche
-
HIV-1 T cell epitopes targeted to Rhesus macaque CD40 and DCIR: A comparative study of prototype dendritic cell targeting therapeutic vaccine candidates
(PLoS ONE. vol. 13, n° 11, pp. e0207794, 2018-11-30)Article de revueLibre accès -
Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial
(AIDS. Official journal of the international AIDS Society. vol. 33, n° 2, pp. 279-284, 2019-02-01)Article de revue -
Prevention of Ebola virus disease through vaccination: where we are in 2018
(Lancet. vol. 392, n° 10149, pp. 787-790, 2018-09-01)Article de revue -
Long-lasting severe immune dysfunction in Ebola virus disease survivors
(Nature Communications. vol. 11, n° 1, pp. 3730, 2020)Article de revueLibre accès -
Analyzing cellular immunogenicity in vaccine clinical trials: a new statistical method including non-specific responses for accurate estimation of vaccine effect
(Journal of Immunological Methods. vol. 477, pp. 112711, 2020)Article de revue -
Multi-arm, multi-stage randomised controlled trials for evaluating therapeutic HIV cure interventions
(The Lancet HIV. vol. 6, n° 5, pp. e334-e340, 2019-05)Article de revueLibre accès -
T-cell and Transcriptomic Responses to Prime-boost Strategies of 3 HIV Vaccines (MVA HIV-B
(AIDS Research and Human Retroviruses. pp. 16-16, 2018-10)Article de revue -
Durable natural killer cell responses after heterologous two-dose Ebola vaccination
(NPJ vaccines. vol. 6, n° 1, pp. 19, 2021-01-29)Article de revueLibre accès -
A randomized placebo-controlled efficacy study of a prime boost therapeutic vaccination strategy in HIV-1 infected individuals: VRI02 ANRS 149 LIGHT Phase II trial
(Journal of Virology, 2021-02-10)Article de revueLibre accès -
Immune Alterations in a Patient with SARS-CoV-2-Related Acute Respiratory Distress Syndrome
(Journal of Clinical Immunology. vol. 40, n° 8, pp. 1082-1092, 2020)Article de revueLibre accès